21 results on '"Zeng, Yuanying"'
Search Results
2. Long Journey to Freedom: An Interpretation of Hullabaloo in the Guava Orchard from the Perspective of Existentialism
3. Anti-bacterial and anti-viral nanchangmycin displays anti-myeloma activity by targeting Otub1 and c-Maf
4. The Class I PI3K inhibitor S14161 induces autophagy in malignant blood cells by modulating the Beclin 1/Vps34 complex
5. Neutrophil gelatinase-associated lipocalin predicts myocardial dysfunction and mortality in severe sepsis and septic shock
6. COVID-19 with cystic features on computed tomography: A case report
7. The impact of individual lifestyle and status on the acquisition of COVID-19: A case—Control study
8. Novel conjugates of endoperoxide and 4-anilinoquinazoline induce myeloma cell apoptosis by inhibiting the IGF1-R/AKT/mTOR signaling pathway
9. The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival
10. Correction: A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma
11. The transmembrane protein TMEPAI induces myeloma cell apoptosis by promoting degradation of the c-Maf transcription factor
12. Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis
13. The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis
14. Ring finger protein 6 promotes breast cancer cell proliferation by stabilizing estrogen receptor alpha
15. An inhibitor of cholesterol absorption displays anti-myeloma activity by targeting the JAK2-STAT3 signaling pathway
16. The Ring Finger Protein RNF6 Induces Leukemia Cell Proliferation as a Direct Target of Pre-B-cell Leukemia Homeobox 1
17. COVID-19 with cystic features on computed tomography: A case report.
18. SC06, a novel small molecule compound, displays preclinical activity against multiple myeloma by disrupting the mTOR signaling pathway
19. A Novel PI3K Inhibitor Identified By a High Throughput Virtual Screen Displays Potent Activity Against Multiple Myeloma
20. A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma
21. A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.